《COVID-19 大流行期间的癌症患者管理：ESMO 多学科专家共识》
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus.
机构信息
Department of Oncology and Hemato-Oncology, Division of Early Drug Development, European Institute of Oncology, IRCCS and University of Milano, Milan, Italy.
Gynaecology Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK.
出版信息
Ann Oncol. 2020 Oct;31(10):1320-1335. doi: 10.1016/j.annonc.2020.07.010. Epub 2020 Jul 31.
Abstract
We established an international consortium to review and discuss relevant clinical evidence in order to develop expert consensus statements related to cancer management during the severe acute respiratory syndrome coronavirus 2-related disease (COVID-19) pandemic. The steering committee prepared 10 working packages addressing significant clinical questions from diagnosis to surgery. During a virtual consensus meeting of 62 global experts and one patient advocate, led by the European Society for Medical Oncology, statements were discussed, amended and voted upon. When consensus could not be reached, the panel revised statements until a consensus was reached. Overall, the expert panel agreed on 28 consensus statements that can be used to overcome many of the clinical and technical areas of uncertainty ranging from diagnosis to therapeutic planning and treatment during the COVID-19 pandemic.
摘要
我们成立了一个国际联盟，旨在审查和讨论相关的临床证据，以制定与严重急性呼吸系统综合征冠状病毒 2 相关疾病（COVID-19）大流行期间癌症管理相关的专家共识声明。指导委员会编写了 10 个工作包，涉及从诊断到手术的重大临床问题。在由欧洲肿瘤内科学会牵头的一场有 62 位全球专家和一位患者代表参加的虚拟共识会议上，对这些声明进行了讨论、修订和投票。当无法达成共识时，专家组会修改声明，直到达成共识。总的来说，专家组就 28 条共识声明达成一致，这些声明可用于克服从诊断到治疗计划和 COVID-19 大流行期间治疗等许多不确定的临床和技术领域。
相似文献
1
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus.《COVID-19 大流行期间的癌症患者管理：ESMO 多学科专家共识》
Ann Oncol. 2020 Oct;31(10):1320-1335. doi: 10.1016/j.annonc.2020.07.010. Epub 2020 Jul 31.
2
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus.在2019冠状病毒病大流行期间管理血液系统癌症患者：ESMO-EHA跨学科专家共识
ESMO Open. 2022 Apr;7(2):100403. doi: 10.1016/j.esmoop.2022.100403. Epub 2022 Jan 28.
3
Clinical research disruption in the post-COVID-19 era: will the pandemic lead to change?新冠疫情后时代的临床研究中断：这场大流行会带来改变吗？
ESMO Open. 2020 Oct;5(5):e000924. doi: 10.1136/esmoopen-2020-000924.
4
Delivering Cancer Care During the COVID-19 Pandemic: Recommendations and Lessons Learned From ASCO Global Webinars.在2019冠状病毒病大流行期间提供癌症护理：美国临床肿瘤学会全球网络研讨会的建议及经验教训
JCO Glob Oncol. 2020 Sep;6:1461-1471. doi: 10.1200/GO.20.00423.
5
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.新型冠状病毒病 2019（COVID-19）大流行期间癌症患者管理的实用方法：国际协作组。
Oncologist. 2020 Jun;25(6):e936-e945. doi: 10.1634/theoncologist.2020-0213. Epub 2020 Apr 27.
6
COVID-19 and cancer care: what do international guidelines say?新型冠状病毒肺炎与癌症照护：国际指引怎么说？
Med Oncol. 2020 Aug 7;37(9):80. doi: 10.1007/s12032-020-01406-5.
7
COVID-19 pneumonia and immune-related pneumonitis: critical issues on differential diagnosis, potential interactions, and management.COVID-19 肺炎与免疫相关肺炎：鉴别诊断、潜在相互作用及处理的关键问题。
Expert Opin Biol Ther. 2020 Sep;20(9):959-964. doi: 10.1080/14712598.2020.1789097. Epub 2020 Jul 2.
8
ESMO management and treatment adapted recommendations in the COVID-19 era: gynaecological malignancies.ESMO 在 COVID-19 时代的管理和治疗适应建议：妇科恶性肿瘤。
ESMO Open. 2020 Jul;5(Suppl 3). doi: 10.1136/esmoopen-2020-000827.
9
Providing optimal interventional oncology procedures at one of the COVID-19 referral center in Italy.在意大利的一家 COVID-19 转诊中心提供最佳的介入肿瘤学治疗。
Med Oncol. 2020 Aug 9;37(9):83. doi: 10.1007/s12032-020-01405-6.
10
Multidisciplinary care of epidermolysis bullosa during the COVID-19 pandemic-Consensus: Recommendations by an international panel of experts.新型冠状病毒肺炎大流行期间大疱性表皮松解症的多学科护理——共识：国际专家小组的建议
J Am Acad Dermatol. 2020 Oct;83(4):1222-1224. doi: 10.1016/j.jaad.2020.06.1023. Epub 2020 Jul 16.
引用本文的文献
1
Standards and practice recommendations for Telehealth in Oncology: MASCC endorsed practice recommendations developed by the American Society of Clinical Oncology.肿瘤学远程医疗的标准与实践建议：MASCC认可的由美国临床肿瘤学会制定的实践建议。
Support Care Cancer. 2025 Aug 2;33(8):743. doi: 10.1007/s00520-025-09808-9.
2
Long-acting lipegfilgrastim and antimicrobials as vigorous primary prophylaxis in bendamustine-treated patients with indolent B cell non-Hodgkin lymphoma: a multicentric real-life experience.长效聚乙二醇非格司亭与抗菌药物作为苯达莫司汀治疗的惰性B细胞非霍奇金淋巴瘤患者的强效一级预防：一项多中心真实世界经验
Support Care Cancer. 2025 Jul 14;33(8):691. doi: 10.1007/s00520-025-09743-9.
3
Chinese expert consensus on the application of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy (2023 edition).聚乙二醇化重组人粒细胞集落刺激因子在同步放化疗中应用的中国专家共识（2023年版）
Precis Radiat Oncol. 2023 Sep 4;7(3):150-159. doi: 10.1002/pro6.1201. eCollection 2023 Sep.
4
How Can Oncology Nurses and Advanced Practice Providers Reduce the Burden of Chemotherapy-Induced Febrile Neutropenia in the US?美国肿瘤护士和高级执业提供者如何减轻化疗引起的发热性中性粒细胞减少症的负担？
J Adv Pract Oncol. 2024 May 22:1-15. doi: 10.6004/jadpro.2024.15.8.5.
5
Optimizing Virtual Follow-Up Care: Realist Evaluation of Experiences and Perspectives of Patients With Breast and Prostate Cancer.优化虚拟随访护理：对乳腺癌和前列腺癌患者经历及观点的现实主义评价
J Med Internet Res. 2025 Jan 3;27:e65148. doi: 10.2196/65148.
6
Impact of COVID-19 on hospital visit behaviour in cancer patients in Japan: a nationwide study.新冠疫情对日本癌症患者就医行为的影响：一项全国性研究。
BMJ Open. 2024 Dec 26;14(12):e084630. doi: 10.1136/bmjopen-2024-084630.
7
Assessment of patient satisfaction levels with teleconsultation services at a tertiary care cancer center in a developing country: a cross-sectional study.评估发展中国家一家三级癌症护理中心的远程咨询服务的患者满意度：一项横断面研究。
Support Care Cancer. 2024 Nov 30;32(12):838. doi: 10.1007/s00520-024-09051-8.
8
Changes in clinical presentation, management, and survival outcomes in patients affected by colorectal cancer following COVID-19 pandemic.2019年冠状病毒病大流行后受结直肠癌影响患者的临床表现、管理及生存结果的变化
Oncologist. 2024 Nov 26. doi: 10.1093/oncolo/oyae310.
9
Three-year survival follow-up of patients with gastrointestinal cancer treated during the COVID-19 pandemic in Spain: data from the PANDORA-TTD20 study.西班牙COVID-19大流行期间接受治疗的胃肠道癌患者的三年生存随访：来自PANDORA-TTD20研究的数据。
Oncologist. 2024 Nov 16. doi: 10.1093/oncolo/oyae300.
10
Impact of COVID-19 on outcomes with teclistamab in patients with relapsed/refractory multiple myeloma in the phase 1/2 MajesTEC-1 study.在1/2期MajesTEC-1研究中，COVID-19对复发/难治性多发性骨髓瘤患者使用替西帕单抗治疗结局的影响。
Blood Cancer J. 2024 Oct 21;14(1):186. doi: 10.1038/s41408-024-01160-1.
本文引用的文献
1
ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer.ESMO 管理和治疗适应 COVID-19 时代的建议：肺癌。
ESMO Open. 2020 Jun;5(Suppl 3). doi: 10.1136/esmoopen-2020-000820.
2
Oncology Treatment in the Era of COVID-19: We Cannot Afford to Hit the Pause Button.COVID-19时代的肿瘤治疗：我们不能按下暂停键。
Clin Pharmacol Ther. 2020 Sep;108(3):422-424. doi: 10.1002/cpt.1920. Epub 2020 Jun 27.
3
Association of the Coronavirus Disease 2019 (COVID-19) Outbreak With Enrollment in Cancer Clinical Trials.新型冠状病毒病 2019（COVID-19）疫情与癌症临床试验入组的相关性。
JAMA Netw Open. 2020 Jun 1;3(6):e2010651. doi: 10.1001/jamanetworkopen.2020.10651.
4
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study.接受化疗或其他抗癌治疗的癌症患者的 COVID-19 死亡率：一项前瞻性队列研究。
Lancet. 2020 Jun 20;395(10241):1919-1926. doi: 10.1016/S0140-6736(20)31173-9. Epub 2020 May 28.
5
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.COVID-19 对癌症患者的临床影响（CCC19）：一项队列研究。
Lancet. 2020 Jun 20;395(10241):1907-1918. doi: 10.1016/S0140-6736(20)31187-9. Epub 2020 May 28.
6
ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer.ESMO 管理和治疗适应 COVID-19 时代的建议：乳腺癌。
ESMO Open. 2020 May;5(Suppl 3):e000793. doi: 10.1136/esmoopen-2020-000793.
7
Dynamic interventions to control COVID-19 pandemic: a multivariate prediction modelling study comparing 16 worldwide countries.动态干预控制 COVID-19 大流行：比较全球 16 个国家的多变量预测建模研究。
Eur J Epidemiol. 2020 May;35(5):389-399. doi: 10.1007/s10654-020-00649-w. Epub 2020 May 19.
8
Changing Oncology Treatment Paradigms in the COVID-19 Pandemic.新冠疫情期间肿瘤治疗模式的转变
Clin Colorectal Cancer. 2020 Sep;19(3):153-155. doi: 10.1016/j.clcc.2020.05.002. Epub 2020 May 14.
9
Granulocyte-colony stimulating factor in COVID-19: Is it stimulating more than just the bone marrow?新冠病毒肺炎中的粒细胞集落刺激因子：它的刺激作用是否不止于骨髓？
Am J Hematol. 2020 Aug;95(8):E210-E213. doi: 10.1002/ajh.25870. Epub 2020 Jul 1.
10
Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 Pandemic.在 COVID-19 大流行期间，接受根治性放疗的肺癌患者的放疗分割减少。
Clin Oncol (R Coll Radiol). 2020 Aug;32(8):481-489. doi: 10.1016/j.clon.2020.05.001. Epub 2020 May 13.
Zotero 插件